We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with chronic rhinitis who had ...
Patients with moderate to severe allergic rhinitis (AR) often experience years of uncontrolled symptoms, worsened quality of ...
An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...
Ablation of the posterior nasal nerve using the NEUROMARK system led to greater reductions in nasal symptoms and improvements ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients with allergic rhinitis (AR), misdiagnosis ...
The Cigna Group CI recently announced that it will start covering RhinAer, a minimally invasive solution for chronic rhinitis, starting Sept. 15, 2025. This move highlights the increasing confidence ...
GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced three-month data from ...
Verywell Health on MSN
What are my allergy treatment options?
There’s no cure for allergies, but treatment can improve your quality of life ...
Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other allergic conditions have improved the quality of care for seasonal allergies ...
GALWAY, Ireland, Nov. 13, 2023 /PRNewswire/ -- Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced a ...
The "Allergic Rhinitis Market- A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results